COMPLETED

Incorporating Positive Affect Promoting Activities Into Cognitive Behavioral Therapies

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this study, the investigators will test whether the incorporation of positive affect promoting activities in treatment sessions improves outcomes in the context of CBT for depression and DBT for problems of emotion dysregulation. In clinics focused on each of these treatments, the investigators will evaluate these treatments with and without the addition of positive affect promoting activities.

Official Title

Incorporating Positive Affect Into Cognitive Behavioral Therapy for Depression and Dialectical Behavior Therapy for Borderline Personality Disorder and Severe Emotion Dysregulation

Quick Facts

Study Start:2022-09-01
Study Completion:2024-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06432959

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 18 years old or older
  2. 2. residence in the state of Ohio
  3. 3. able and willing to give informed consent
  1. 1. current or past diagnosis of bipolar disorder or a psychotic disorder
  2. 2. presence of a psychiatric disorder other than Major Depressive Disorder (MDD) or BPD, if it constitutes the predominant aspect of the clinical presentation and if it requires treatment other than that being offered (including substance use disorders involving heroin, cocaine, and methamphetamine deemed inappropriate at pre-screening)
  3. 3. currently participating in a psychosocial treatment for an emotional disorder, including any individual psychotherapy
  4. 4. if on psychiatric medication, no changes to medication regimen (drugs or dosage) in the past month and no intention to modify medication regimen for the next 12 weeks
  5. 5. clear indication of secondary gain (e.g., court-ordered treatment)
  6. 6. current suicide risk of medical instability (e.g., low weight) to preclude treatment on an outpatient basis

Contacts and Locations

Study Locations (Sites)

Department of Psychology, The Ohio State University
Columbus, Ohio, 43210
United States

Collaborators and Investigators

Sponsor: Ohio State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-01
Study Completion Date2024-04-01

Study Record Updates

Study Start Date2022-09-01
Study Completion Date2024-04-01

Terms related to this study

Additional Relevant MeSH Terms

  • Depression
  • Borderline Personality Disorder
  • Emotion Regulation